We use cookies to make this site as useful as possible. By continuing browsing we assume that you agree to accept cookies in accordance with our cookie policy.
To find out more or to change your cookie settings at any time, see our cookie policy. OK

  • About
  • Careers
  • Select Dechra business
    • Dechra Pharmaceuticals PLC
    • Dechra Manufacturing
  • Sign in
  • Select country
    • Danmark
    • Suomi
    • France
    • Deutschland
    • Österreich
    • Nederland
    • Norge
    • Ireland
    • Italia
    • España
    • Portugal
    • Sverige
    • United Kingdom
    • België
    • USA
    • Canada
    • Polska
    • Hrvatska
    • Bosna i Hercegovina
    • Slovenija
    • Australia
    • México
    • Global
    • By clicking a flag you will be leaving this country website to access another site in the Dechra group not applicable to your territory and which may have different legislation
Dechra Veterinary Products
Your materials (0)
  • Products
  • Therapy Areas
  • Academy
  • News
  • Events
  • Support Materials
  • Contact
  • Your materials (0)
  • You are here:
  • Home
  • / News
  • Back
  • You are here:
  • News

News

Dechra unveils Rexxolide®, new respiratory relief for BRD, SRD and foot rot diseases

15 March 2021

Dechra Veterinary Products has launched a new respiratory relief product to treat bovine respiratory disease (BRD), swine respiratory disease (SRD) and infectious pododermatitis (foot rot) in sheep.

Rexxolide® contains 100 mg/ml of tulathromycin, which is widely used and trusted when treating BRD and SRD. It also has a single dose and low injection volume of 1 ml/40 kg BW, making it convenient for both user and animal.

The medication has an immune-modulating and anti-inflammatory action and offers equal viscosity and syringability as other products on the market1. It can be used for treatment and metaphylaxis of BRD and SRD and offers early-stage treatment for infectious pododermatitis

Dechra’s Equine and Food Producing Animal Brand Manager, Emma Jennings said: “Launching Rexxolide® into the market provides an alternative option to existing BRD, SRD and foot rot treatments for farm vets across the UK and Ireland.

“We support an integrated approach to the control of BRD, with good husbandry, early detection and correct therapy being vital tools in managing the multi-factorial condition.”

Rexxolide® is available in 50ml and 100ml vials. For more information visit www.dechra.co.uk.

1 11022021 Reference file – Biowaver Canada

 

 

.

 

Back to news list

Dechra unveils Rexxolide®, new respiratory relief for BRD, SRD and foot rot diseases /Default.aspx?ID=1011&newsid=5432&Action=1&M=NewsV2&PID=5356

Contact

info.uk@dechra.com

 
 
 
 
 
 
 
 
 
 
 
 
Website: Co3
  • Modern Slavery Statement
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Sitemap
  • Select Dechra business
    • Dechra Pharmaceuticals PLC
    • Dechra Manufacturing

Sign in

Sign in

Help: Forgot password?

 Don't have a Dechra UK Website account?

It is free and only takes a few minutes - Sign up today ensuring you are on your local country site first.

Register here